CTMX
Price
$2.50
Change
+$0.02 (+0.81%)
Updated
Jul 3 closing price
Capitalization
393.86M
33 days until earnings call
NRXS
Price
$2.58
Change
+$0.17 (+7.05%)
Updated
Jul 3 closing price
Capitalization
24.58M
75 days until earnings call
Interact to see
Advertisement

CTMX vs NRXS

Header iconCTMX vs NRXS Comparison
Open Charts CTMX vs NRXSBanner chart's image
CytomX Therapeutics
Price$2.50
Change+$0.02 (+0.81%)
Volume$755.78K
Capitalization393.86M
Neuraxis
Price$2.58
Change+$0.17 (+7.05%)
Volume$134.06K
Capitalization24.58M
CTMX vs NRXS Comparison Chart in %
Loading...
CTMX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NRXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CTMX vs. NRXS commentary
Jul 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CTMX is a StrongBuy and NRXS is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 05, 2025
Stock price -- (CTMX: $2.50 vs. NRXS: $2.58)
Brand notoriety: CTMX and NRXS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CTMX: 12% vs. NRXS: 6%
Market capitalization -- CTMX: $393.86M vs. NRXS: $24.58M
CTMX [@Biotechnology] is valued at $393.86M. NRXS’s [@Biotechnology] market capitalization is $24.58M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CTMX’s FA Score shows that 0 FA rating(s) are green whileNRXS’s FA Score has 0 green FA rating(s).

  • CTMX’s FA Score: 0 green, 5 red.
  • NRXS’s FA Score: 0 green, 5 red.
According to our system of comparison, CTMX is a better buy in the long-term than NRXS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CTMX’s TA Score shows that 4 TA indicator(s) are bullish while NRXS’s TA Score has 6 bullish TA indicator(s).

  • CTMX’s TA Score: 4 bullish, 4 bearish.
  • NRXS’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, NRXS is a better buy in the short-term than CTMX.

Price Growth

CTMX (@Biotechnology) experienced а +8.23% price change this week, while NRXS (@Biotechnology) price change was +2.38% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

CTMX is expected to report earnings on Aug 07, 2025.

NRXS is expected to report earnings on Sep 18, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CTMX($394M) has a higher market cap than NRXS($24.6M). CTMX YTD gains are higher at: 142.718 vs. NRXS (9.787). CTMX has higher annual earnings (EBITDA): 37.6M vs. NRXS (-8.11M). CTMX has more cash in the bank: 79.9M vs. NRXS (2.01M). NRXS has less debt than CTMX: NRXS (389K) vs CTMX (8.15M). CTMX has higher revenues than NRXS: CTMX (148M) vs NRXS (2.94M).
CTMXNRXSCTMX / NRXS
Capitalization394M24.6M1,602%
EBITDA37.6M-8.11M-464%
Gain YTD142.7189.7871,458%
P/E Ratio5.21N/A-
Revenue148M2.94M5,043%
Total Cash79.9M2.01M3,985%
Total Debt8.15M389K2,095%
FUNDAMENTALS RATINGS
CTMX: Fundamental Ratings
CTMX
OUTLOOK RATING
1..100
4
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
74
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CTMXNRXS
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
79%
MACD
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
82%
Declines
ODDS (%)
Bearish Trend 17 days ago
88%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 4 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
CTMX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NRXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TOPPY14.07N/A
N/A
TOPPAN HOLDINGS INC.
TYCB55.00N/A
N/A
Calvin B. Taylor Bankshares, Inc.
AITUY11.86N/A
N/A
Anritsu Corp.
PGNN10.02-0.06
-0.59%
Paragon Financial Solutions, Inc. (TN)
DTEGF36.54-0.72
-1.92%
Deutsche Telekom AG

NRXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRXS has been loosely correlated with CVM. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if NRXS jumps, then CVM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRXS
1D Price
Change %
NRXS100%
+7.05%
CVM - NRXS
58%
Loosely correlated
-1.19%
CTMX - NRXS
25%
Poorly correlated
+0.81%
NGNE - NRXS
24%
Poorly correlated
+4.69%
MRVI - NRXS
24%
Poorly correlated
+0.75%
TSHA - NRXS
23%
Poorly correlated
+0.82%
More